Synopsis of recent research by authors named "Seiko Miyazaki"
- Seiko Miyazaki's recent research primarily focuses on evaluating drug safety and effectiveness, particularly in special populations such as pregnant and lactating women, by analyzing data from consultation cases and pharmacovigilance studies in Japan.
- The research highlights significant discrepancies in drug approval processes and indication expansions between Japan, the United States, and Europe, emphasizing the need for improved post-marketing safety measures and timely updates to drug indications in Japan.
- Additionally, Miyazaki's work on harmonizing pharmacopoeial standards underscores the importance of controlling pharmaceutical quality amid the globalization of drug supply chains, advocating for the incorporation of international guidelines into local pharmacopoeias.
